Carol Kolar

1.1k total citations
46 papers, 832 citations indexed

About

Carol Kolar is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Carol Kolar has authored 46 papers receiving a total of 832 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 11 papers in Oncology and 7 papers in Surgery. Recurrent topics in Carol Kolar's work include Biochemical and Molecular Research (5 papers), Carcinogens and Genotoxicity Assessment (5 papers) and Pancreatic function and diabetes (5 papers). Carol Kolar is often cited by papers focused on Biochemical and Molecular Research (5 papers), Carcinogens and Genotoxicity Assessment (5 papers) and Pancreatic function and diabetes (5 papers). Carol Kolar collaborates with scholars based in United States, Russia and Germany. Carol Kolar's co-authors include Terence Lawson, Jinqian Liu, William H. Gmeiner, J.R. Brunner, Donald W. Miller, Ferenc Nagy, Éva Ádám, E. Schäfer, Ohára Augusto and Eleanor G. Rogan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Carol Kolar

44 papers receiving 801 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carol Kolar United States 19 523 182 99 94 79 46 832
B. K. Sathyanarayana United States 11 472 0.9× 121 0.7× 81 0.8× 65 0.7× 51 0.6× 17 692
Guohui Cui China 17 628 1.2× 173 1.0× 119 1.2× 88 0.9× 67 0.8× 72 1.1k
Ramachandran Rashmi United States 15 717 1.4× 136 0.7× 169 1.7× 59 0.6× 42 0.5× 18 1.0k
Stéphane Vispé France 16 952 1.8× 243 1.3× 139 1.4× 102 1.1× 52 0.7× 23 1.1k
Qing Wen China 19 479 0.9× 162 0.9× 133 1.3× 179 1.9× 49 0.6× 41 926
Michele F. Rega United States 17 502 1.0× 92 0.5× 32 0.3× 137 1.5× 38 0.5× 28 762
Sina Sareth United States 8 621 1.2× 146 0.8× 45 0.5× 68 0.7× 62 0.8× 9 844
Taijo Takahashi Japan 19 968 1.9× 277 1.5× 154 1.6× 96 1.0× 97 1.2× 59 1.3k
Linda Rickardson Sweden 18 705 1.3× 290 1.6× 219 2.2× 82 0.9× 35 0.4× 28 1.1k
Kwang‐Hoe Chung South Korea 20 433 0.8× 87 0.5× 77 0.8× 116 1.2× 45 0.6× 36 963

Countries citing papers authored by Carol Kolar

Since Specialization
Citations

This map shows the geographic impact of Carol Kolar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carol Kolar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carol Kolar more than expected).

Fields of papers citing papers by Carol Kolar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carol Kolar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carol Kolar. The network helps show where Carol Kolar may publish in the future.

Co-authorship network of co-authors of Carol Kolar

This figure shows the co-authorship network connecting the top 25 collaborators of Carol Kolar. A scholar is included among the top collaborators of Carol Kolar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carol Kolar. Carol Kolar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Bessho, Mika, et al.. (2021). Selective killing of homologous recombination-deficient cancer cell lines by inhibitors of the RPA:RAD52 protein-protein interaction. PLoS ONE. 16(3). e0248941–e0248941. 16 indexed citations
3.
Kolar, Carol, et al.. (2019). A simple fluorescent assay for the discovery of protein-protein interaction inhibitors. Analytical Biochemistry. 569. 46–52. 8 indexed citations
4.
Mir, Riyaz Ahmad, Nicholas P. Schafer, Peter D. Simone, et al.. (2016). Biophysical characterization and modeling of human Ecdysoneless (ECD) protein supports a scaffolding function. AIMS Biophysics. 3(1). 195–210. 4 indexed citations
5.
Liu, Shengqin, et al.. (2014). Interplay of DNA damage and cell cycle signaling at the level of human replication protein A. DNA repair. 21. 12–23. 16 indexed citations
6.
Kizhake, Smitha, et al.. (2013). The paradox of conformational constraint in the design of Cbl(TKB)-binding peptides. Scientific Reports. 3(1). 1639–1639. 18 indexed citations
7.
Aschebrook‐Kilfoy, Briseis, Nicholas J. Ollberding, Carol Kolar, et al.. (2012). Meat intake and risk of non-Hodgkin lymphoma. Cancer Causes & Control. 23(10). 1681–1692. 20 indexed citations
8.
Kolar, Carol, et al.. (2011). A real‐time and hands‐on research course in protein purification and characterization: Purification and crystal growth of human inosine triphosphate pyrophosphatase. Biochemistry and Molecular Biology Education. 39(1). 28–37. 10 indexed citations
9.
Filenko, Nina A., Carol Kolar, John T. West, et al.. (2011). The Role of Histone H4 Biotinylation in the Structure of Nucleosomes. PLoS ONE. 6(1). e16299–e16299. 37 indexed citations
10.
Bao, Baolong, et al.. (2010). Holocarboxylase synthetase is a chromatin protein and interacts directly with histone H3 to mediate biotinylation of K9 and K18. The Journal of Nutritional Biochemistry. 22(5). 470–475. 31 indexed citations
11.
Chiu, Brian C.‐H., Carol Kolar, Susan M. Gapstur, et al.. (2005). Association of NAT and GST polymorphisms with non‐Hodgkin's lymphoma: a population‐based case–control study. British Journal of Haematology. 128(5). 610–615. 44 indexed citations
12.
Lawson, Terence & Carol Kolar. (2002). Human prostate epithelial cells metabolize chemicals of dietary origin to mutagens. Cancer Letters. 175(2). 141–146. 20 indexed citations
13.
Wang, Xiaojie, et al.. (2000). Metabolism of the Hamster Pancreatic Carcinogen Methyl-2-Oxopropylnitrosamine by Hamster Liver and Pancreas. International Journal of Gastrointestinal Cancer. 27(2). 105–112. 1 indexed citations
14.
Liu, Jinqian, et al.. (1999). Increased Cytotoxicity and Decreased In Vivo Toxicity of FdUMP[10] Relative to 5-FU. Nucleosides and Nucleotides. 18(8). 1789–1802. 24 indexed citations
15.
Kolar, Carol, Thomas C. Caffrey, Michael A. Hollingsworth, et al.. (1997). Duct Epithelial Cells Cultured from Human Pancreas Processed for Transplantation Retain Differentiated Ductal Characteristics. Pancreas. 15(3). 265–271. 12 indexed citations
16.
Ádám, Éva, László Kozma‐Bognár, Carol Kolar, E. Schäfer, & Ferenc Nagy. (1996). The Tissue-Specific Expression of a Tobacco Phytochrome B Gene. PLANT PHYSIOLOGY. 110(4). 1081–1088. 30 indexed citations
17.
Lawson, Terence & Carol Kolar. (1992). Mutation of V79 cells by N-dialkylnitrosamines after activation by hamster pancreas duct cells. Mutation Research/Environmental Mutagenesis and Related Subjects. 272(2). 139–144. 4 indexed citations
18.
Lawson, Terence, et al.. (1990). The mutation of V79 cells by N-nitrosobis(2-oxopropyl)amine activated by pancreas acinar and duct tissue from Syrian hamsters and MRC-Wistar rats. Mutation Research/Genetic Toxicology. 240(4). 237–240. 6 indexed citations
19.
Lawson, Terence, et al.. (1989). The activation of 3H-labeled N-nitrosobis(2-oxopropyl)amine by isolated hamster pancreas cells. Journal of Cancer Research and Clinical Oncology. 115(1). 47–52. 5 indexed citations
20.
Carroll, Robert J., M.P. Thompson, J.R. Brunner, & Carol Kolar. (1967). Aggregate size of casein micelles prepared by low temperature centrifugation of skimmilk. Journal of Dairy Science. 50. 6941. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026